RecruitingNot ApplicableNCT07069413

Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children

Sibwatch: Optimizing Intervention Options for Infants and Toddlers With a High Likelihood of Social Communication Delays and Language Disorder


Sponsor

University of Texas at Austin

Enrollment

140 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This rigorous randomized controlled trial will evaluate the efficacy and acceptability of a preemptive, telehealth intervention (tele-ImPACT) in a large, representative sample of infant siblings of autistic children, who are known to be at high likelihood of receiving a future diagnosis of autism and/or developmental language disorder (HL-Sibs). If our hypotheses are supported, this innovative and interdisciplinary study will provide empirical support for a novel approach to treatment that is theoretically motivated and developmentally informed, as well as accessible for and acceptable to families, and will lend new insights into the developmental windows in which, mechanisms by which, and subgroups for which the treatment works. Such findings would have strong implications for research, policy, theory, and practice in young children at risk for autism and/or language disorder.


Eligibility

Min Age: 6 MonthsMax Age: 24 Months

Inclusion Criteria2

  • chronological age between 6-24 months
  • has at least one older biological sibling diagnosed with autism

Exclusion Criteria4

  • adverse neurological history
  • primary sensory deficit (hearing or visual impairment)
  • pre-term birth (gestation <37 weeks)
  • pre-existing diagnosis of autism or language delay

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALtele-ImPACT

Participants will receive 12 weeks of Project ImPACT intervention as delivered via Telehealth


Locations(2)

VUMC

Nashville, Tennessee, United States

Little Longhorn Lab

Austin, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07069413